125 related articles for article (PubMed ID: 12503503)
1. [Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem?].
Chalumeau M; Chéron G; Assathiany R; Moulin F; Bavoux F; Bréart G; Pons G
Arch Pediatr; 2002 Nov; 9(11):1128-36. PubMed ID: 12503503
[TBL] [Abstract][Full Text] [Related]
2. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
Chalumeau M; Duijvestijn YC
Cochrane Database Syst Rev; 2013 May; (5):CD003124. PubMed ID: 23728642
[TBL] [Abstract][Full Text] [Related]
3. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
Duijvestijn YC; Mourdi N; Smucny J; Pons G; Chalumeau M
Cochrane Database Syst Rev; 2009 Jan; (1):CD003124. PubMed ID: 19160217
[TBL] [Abstract][Full Text] [Related]
4. Use of mucolytics in COPD: A Delphi consensus study.
Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
[TBL] [Abstract][Full Text] [Related]
5. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey.
Mallet P; Mourdi N; Dubus JC; Bavoux F; Boyer-Gervoise MJ; Jean-Pastor MJ; Chalumeau M
PLoS One; 2011; 6(7):e22792. PubMed ID: 21818391
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
7. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Chong J; Cates CJ
Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
[TBL] [Abstract][Full Text] [Related]
8. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
9. [Acute cough in infants: impact of national guidelines on medical practices in a French department].
Alauzet F; Banide MC; Pailhes C; Blanc S; Montaudié I; Piccini-Bailly C; Berlioz-Baudoin M; Bégassat M; Albertini M; Giovannini-Chami L
Arch Pediatr; 2014 May; 21(5):461-8. PubMed ID: 24721414
[TBL] [Abstract][Full Text] [Related]
10. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effect of three oral mucolytics on the ultrastructure of the tracheal epithelium in rabbits.
Konrádová V; Vávrová V; Sulová J
Respiration; 1985; 48(1):50-7. PubMed ID: 3927460
[TBL] [Abstract][Full Text] [Related]
12. [Mucolytics and mucoregulators].
Sternon J
Rev Med Brux; 1987 Mar; 8(3):149-51. PubMed ID: 3589262
[No Abstract] [Full Text] [Related]
13. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
14. Theory and practice of the use of expectorants reviewed from clinical aspects.
Nagy G
Ther Hung; 1984; 32(1):6-12. PubMed ID: 6400475
[No Abstract] [Full Text] [Related]
15. Prescribers' indications for drugs in childhood: a survey of five European countries (Spain, France, Bulgaria, Slovakia and Russia).
Sanz EJ; Hernández MA; Ratchina S; Stratchounsky L; Peiré MA; Lapeyre Mestre M; Horen B; Kriska M; Krajnakova H; Momcheva H; Encheva D; Martínez-Mir I; Palop V
Acta Paediatr; 2005 Dec; 94(12):1784-90. PubMed ID: 16421040
[TBL] [Abstract][Full Text] [Related]
16. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
17. Effect of carbocysteine on cough reflex to capsaicin in asthmatic patients.
Ishiura Y; Fujimura M; Yamamori C; Nobata K; Myou S; Kurashima K; Michishita Y; Takegoshi T
Br J Clin Pharmacol; 2003 Jun; 55(6):504-10. PubMed ID: 12814442
[TBL] [Abstract][Full Text] [Related]
18. [Mucolytic drugs: towards a contraindication in infants].
Mourdi N; Dubus JC; Bavoux F; Boyer-Gervoise M; Jean-Pastor MJ; Chalumeau M
Arch Pediatr; 2010 Jun; 17(6):735-6. PubMed ID: 20654866
[No Abstract] [Full Text] [Related]
19. Carbocisteine: frequent cutaneous adverse effects.
Prescrire Int; 2007 Feb; 16(87):17. PubMed ID: 17326276
[TBL] [Abstract][Full Text] [Related]
20. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial.
Allegra L; Cordaro CI; Grassi C
Respiration; 1996; 63(3):174-80. PubMed ID: 8739489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]